When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
XLRN - EMA grants PRIME designation to Acceleron's sotatercept
Acceleron Pharma Inc.
The European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to Acceleron Pharma's (NASDAQ:XLRN) sotatercept for the treatment of patients with pulmonary arterial hypertension.
More news on: Acceleron Pharma Inc., Healthcare stocks news,